Immatics N.V. (IMTX)
Nasdaq: IMTX · Biological Products, (No Diagnostic Substances) · Tubingen, DE · filing with the SEC since 2020
Who owns Immatics N.V.
As filed with the SECHolders of 5% or more
6
T. Rowe Price Investment Management, Inc. holds 16.1% of COMMON STOCK, as its SCHEDULE 13G/A filed May 15, 2026 says.
Directors and officers
22
report now, of 22 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
T. Rowe Price Investment Management, Inc.
SCHEDULE 13G/A · filed May 15, 2026 · COMMON STOCK · 15.1% in Aug 14, 2025
RTW Investments, LP
SCHEDULE 13G/A · filed May 15, 2026 · Ordinary Shares, nominal value (euro) 0.01 per share · 8.5% in Feb 17, 2026
Suvretta Capital Management, LLC
SCHEDULE 13G/A · filed Feb 13, 2026 · ordinary shares, nominal value (euro)0.01 per share · 9.9% in Aug 13, 2025
Perceptive Advisors LLC
SCHEDULE 13D/A · filed Aug 27, 2026 · Ordinary Shares, nominal value EUR 0.01 per share
Baker Bros. Advisors LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Ordinary Shares, nominal value EUR 0.01 per share · 9.95% in Nov 14, 2025
Toronto Dominion Bank
SCHEDULE 13G · filed May 15, 2026 · Ordinary shares
Vestal Point Capital, LP
SCHEDULE 13G/A · filed May 15, 2026 · Ordinary Shares, nominal value 0.01 per share · reported falling below 5%, from 5.3% in Feb 14, 2025
Wellington Management Group LLP
SCHEDULE 13G/A · filed Aug 12, 2025 · Common Stock · reported falling below 5%, from 7.1% in May 12, 2025
What IMTX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Immatics Biotechnologies GmbH
An entity · subsidiary · owns, named in the 20-F filed Mar 5, 2026
Immatics NV
An entity · subsidiary · owns, named in the 20-F filed Mar 5, 2026
Immatics NV and Immatics GmbH
An entity · subsidiary · owns, named in the 20-F filed Mar 5, 2026
Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$7.5Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 22 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Edelman Joseph | director | 0 | $0 | 0 | 1 | $7.5M |